Radiotherapy is an independent prognostic marker of favorable prognosis in non‐small cell lung cancer patients after treatment with the immune checkpoint inhibitor, nivolumab

Background It remains unclear why radiation clinically provides a synergistic effect when combined with immune checkpoint inhibitors such as nivolumab. The purpose of our study was to retrospectively evaluate whether the therapeutic efficacy of nivolumab is improved as a result of a history of radio...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Ou Yamaguchi, Kyoichi Kaira, Kosuke Hashimoto, Atsuto Mouri, Yu Miura, Ayako Shiono, Fuyumi Nishihara, Yoshitake Murayama, Shin‐ei Noda, Shingo Kato, Kunihiko Kobayashi, Hiroshi Kagamu
Format: Artigo
Jezik:Inglês
Izdano: Wiley 2019-04-01
Serija:Thoracic Cancer
Teme:
Nivolumab
NSCLC
PD‐1
radiotherapy
synergistic effect
Online dostop:https://doi.org/10.1111/1759-7714.13044
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki